Clinical Trial Update: Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating bortezomib with combination chemotherapy in adults with relapsed or refractory acute lymphoblastic leukemia; trial completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Stanford University | Conditions: B-cell Adult Acute Lymphoblastic Leukemia (ALL), Ph-positive Adult Acute Lymphoblastic Leukemia (ALL) | Phase 2 | Status: COMPLETED | Results posted: 2018-10-09